True Link Financial Advisors’s AbbVie ABBV Stock Holding History

True Link Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$207K	Sell	954 -111	-10%	-$24.6K	0.01%	92
2025 Q4	$243K	Buy	1,065 +134	+14%	+$30.5K	0.01%	96
2025 Q3	$216K	Buy	+931	New	+$190K	0.01%	87
2025 Q2	–	Sell	-1,029	Closed	-$216K	–	88
2025 Q1	$216K	Buy	+1,029	New	+$200K	0.02%	89
2022 Q1	–	Sell	-750	Closed	-$102K	–	129
2021 Q4	$102K	Hold	750	–	–	0.01%	377
2021 Q3	$81K	Buy	+750	New	+$85.7K	0.01%	405

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

True Link Financial Advisors's ABBV Position: Q1 2026 in Review

True Link Financial Advisors reduced its AbbVie (ABBV) stake by 10% in Q1 2026, selling an estimated $24.6K and leaving 954 shares worth $207K. The position accounts for 0.01% of the portfolio, ranked #92.

True Link Financial Advisors first reported a position in ABBV in Q3 2021 and has held it in 6 quarters since. The position peaked at $243K in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

True Link Financial Advisors held 954 shares of AbbVie worth $207K as of Q1 2026.
True Link Financial Advisors sold 111 AbbVie shares in Q1 2026, an estimated $24.6K.
AbbVie made up 0.01% of True Link Financial Advisors's portfolio in Q1 2026, its #92 holding.
True Link Financial Advisors first reported a position in AbbVie in Q3 2021 and has held it in 6 quarters since.
True Link Financial Advisors's AbbVie position peaked at $243K in Q4 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on True Link Financial Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.